Allen S. Melemed - 18 Jan 2022 Form 4 Insider Report for CHIMERIX INC

Role
Chief Medical Officer
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 17:58:25 UTC
Next filing
19 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +240,000 $0.000000 240,000 18 Jan 2022 Common Stock 240,000 $5.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.